Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Parkinson Disease
Interventions
DRUG
recombinant-methionyl human glial cell line-derived neurotrophic factor
Trial Locations (1)
10016
Department of Neurology, New York
All Listed Sponsors
lead
National Center for Research Resources (NCRR)
NIH
NCT00006488 - Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease | Biotech Hunter | Biotech Hunter